Fibrosis Index and FIB4 in Prediction of HCC in Chronic Hepatitis C Patients
International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
www.ijsr.net | Open Access | Fully Refereed | Peer Reviewed International Journal

ISSN: 2319-7064



Research Paper | Cancer Science | Egypt | Volume 8 Issue 7, July 2019

Fibrosis Index and FIB4 in Prediction of HCC in Chronic Hepatitis C Patients

Shabana HR, Deiab AG, Askar MS, Elrakhawy M

Introduction: In Egypt, HCC is now the first cause of cancer related mortality. This is attributed to the heavy burden of chronic HCV (CHC) infection. The increased risk to development of HCC in chronic HCV patients is largely restricted to cirrhotic patients and those with advanced fibrosis. Both FIB-4 and fibrosis index (FI) are considered non-invasive tools for evaluation of hepatic fibrosis, using simple variables. Aim of the Work: This work aims to examine the utility of FIB4 score and FI score in predicting the risk of HCC development in chronic HCV Egyptian patients. Patients and Methods: This study included 111 adult patients (100 males, 11 females) with chronic HCV and untreated HCC (group A) and 222 adult patients (128 males, 94 females) with chronic HCV without HCC (group B). FIB4 was estimated as follows: [Age x AST] / [Platelets x (ALT) 1/2]. FI was estimated as follows: 8.28-[ (0.01x Platelets (109/L) (1.08* (10*serum albumin (gm/L) ].Results: FI and FIB4 scores reported statistically significant high values in group A. The values of FIB4 was 7.15 5.78 in group A compared to 3.42 3.14 in group B (P 0.000). The values of FI score was 3.57 1.07 in group A compared to 2.43 1.08 in group B (P0.000). The Stratified Specific LR for presence of HCC according to the score of FIB4 was (0.07, 1.22 and 2.43) in subjects with score (< 2, 2 4 and 4) respectively. The SSLR concerning HCC presence according to FI score was (0.22, 1.02 and 5.05) in subjects with score (< 2, 2 - 4 and 4) respectively. Conclusion: Both FI and FIB4 scores could be useful tools to predict the risk of development of HCC in Egyptian subjects with chronic HCV. Nevertheless, FI was superior to FIB4 in this aspect. FI 4 is 5.05 times as likely to occur in chronic HCV patients with HCC than those without. So, patients with chronic HCV with FI 4 must be subjected for meticulous follow-up.

Keywords: HCC, FIB4, FI, HCV

Edition: Volume 8 Issue 7, July 2019

Pages: 361 - 364

Share this Article

How to Cite this Article?

Shabana HR, Deiab AG, Askar MS, Elrakhawy M, "Fibrosis Index and FIB4 in Prediction of HCC in Chronic Hepatitis C Patients", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=ART20199398, Volume 8 Issue 7, July 2019, 361 - 364

117 PDF Views | 83 PDF Downloads

Download Article PDF



Similar Articles with Keyword 'FI'

Review Papers, Cancer Science, India, Volume 9 Issue 6, June 2020

Pages: 1489 - 1490

Estimation of Lipid Peroxidase & Micronucleus Status in Oral Cancer

Sonalika Shrivastava, Alibha Rawat, N Ganesh

Share this Article

Case Studies, Cancer Science, India, Volume 9 Issue 1, January 2020

Pages: 1616 - 1619

Clinical Diversities in Basal Cell Carcinoma of the Eyelids

Dr Susan Dsouza, Dr Devesh Agrawal, Dr Vala Mounika Rao, Dr. Nirupama Murali M

Share this Article

Research Paper, Cancer Science, India, Volume 8 Issue 12, December 2019

Pages: 901 - 904

Nuclear Variations in Urothelial Cells - A Diagnostic Tool in Early Detection of Cervical Carcinoma

Sohinder Kaur, M. L. Jain

Share this Article

Research Paper, Cancer Science, Iraq, Volume 8 Issue 7, July 2019

Pages: 1660 - 1664

Study of Molecular Subtypes and Clinic-PathoLogical Features of Breast Cancer in Iraq

Dr. Mohammed Neamah Kadhim

Share this Article

Research Paper, Cancer Science, India, Volume 8 Issue 9, September 2019

Pages: 1318 - 1319

Leukemia Cancer

Harsh D. Ratanghayra

Share this Article
Top